From left to right: Qiming managing partners Gary Rieschel, Duane Kuang, Nisa Leung and William Hu
July 11, 2022 07:41 AM EDTUpdated 10:02 AM
Financing

VC dol­lars keep rolling in as Qim­ing ties a rib­bon on $2.5B Fund VI­II

Amber Tong

Qim­ing Ven­ture Part­ners’ deep pock­ets just got even deep­er.

Al­most two years af­ter clos­ing its sev­enth fund, the sto­ried Chi­nese VC firm has hit …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Am­gen obe­si­ty shot shows 20% weight loss, but dos­ing ques­tions hang over read­out

The Biden ad­min­is­tra­tion wants Medicare and Med­ic­aid to cov­er GLP-1s. Will the Trump White House al­low it?

Sarep­ta li­cens­es Ar­row­head­'s RNA-based rare dis­ease pipeline, promis­ing big biobucks

Ax­some moves to­ward NDA fil­ing for nar­colep­sy drug fol­low­ing pos­i­tive Phase 3 da­ta

Soleno’s rare pe­di­atric dis­ease drug faces PDU­FA de­lay by three months

Up­dat­ed: Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

A service from the Financial Times